Picture of Pliant Therapeutics logo

PLRX — Pliant Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: Pliant Therapeutics Q3 Net Income USD -41.487 Million

Nov 09 (Reuters) - Pliant Therapeutics Q3 operating expenses USD -47.685
million.
* Q3 operating income USD -47.685 million
* Q3 EPS USD -0.7

Recent news on Pliant Therapeutics

See all news